Hoth Therapeutics, Inc. — Director's Dealing 2023

Jul 18, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Hoth Therapeutics, Inc. (HOTH)
CIK: 0001711786
Period of Report: 2023-07-17

Reporting Person: Knie Robb (Director, CEO and President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-07-17	Options	$2.59	A	40000	Acquired	2033-07-17	Common Stock (40000)	Direct

Footnotes

F1: The options were issued pursuant to the Issuer's 2022 Equity Incentive Plan and vested in full upon grant.